Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 33, Issue 12, Pages 14717-14733
Publisher
FASEB
Online
2019-11-06
DOI
10.1096/fj.201901079rr
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relaxin and extracellular matrix remodeling: Mechanisms and signaling pathways
- (2019) Hooi Hooi Ng et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Cardioprotective actions of relaxin
- (2019) Brian Martin et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The SGK1 inhibitor EMD638683, prevents Angiotensin II–induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation
- (2018) Wenqiang Gan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- NLRP3 inflammasome inhibition attenuates silica-induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells
- (2018) Xiang Li et al. EXPERIMENTAL CELL RESEARCH
- Serelaxin inhibits differentiation and fibrotic behaviors of cardiac fibroblasts by suppressing ALK-5/Smad2/3 signaling pathway
- (2018) Xue-ping Wu et al. EXPERIMENTAL CELL RESEARCH
- Extracellular matrix remodeling and cardiac fibrosis
- (2018) Li Li et al. MATRIX BIOLOGY
- NLRP3: A Novel Mediator in Cardiovascular Disease
- (2018) Wenyi Zhou et al. Journal of Immunology Research
- Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
- (2018) Nikolaos G. Frangogiannis MOLECULAR ASPECTS OF MEDICINE
- Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
- (2018) Luigi Ferrucci et al. Nature Reviews Cardiology
- TLR4-dependent upregulation of the platelet NLRP3 inflammasome promotes platelet aggregation in a murine model of hindlimb ischemia
- (2018) Sebastian Vogel et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension
- (2018) Shalini M Krishnan et al. CARDIOVASCULAR RESEARCH
- IL-18 cleavage triggers cardiac inflammation and fibrosis upon β-adrenergic insult
- (2017) Han Xiao et al. EUROPEAN HEART JOURNAL
- ML290 is a biased allosteric agonist at the relaxin receptor RXFP1
- (2017) Martina Kocan et al. Scientific Reports
- Anti-fibrotic actions of relaxin
- (2016) C S Samuel et al. BRITISH JOURNAL OF PHARMACOLOGY
- The actions of relaxin on the human cardiovascular system
- (2016) Mohsin Sarwar et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Biological Basis for Cardiac Repair After Myocardial Infarction
- (2016) Sumanth D. Prabhu et al. CIRCULATION RESEARCH
- Cardiac Fibrosis
- (2016) Joshua G. Travers et al. CIRCULATION RESEARCH
- Expression and function of toll-like receptor 4 and inflammasomes in cardiac fibroblasts and myofibroblasts: IL-1β synthesis, secretion, and degradation
- (2016) Pia Boza et al. MOLECULAR IMMUNOLOGY
- The Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOate
- (2016) Chao Wang et al. Frontiers in Pharmacology
- Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice
- (2015) S M Krishnan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mechanobiology of myofibroblast adhesion in fibrotic cardiac disease
- (2015) A. K. Schroer et al. JOURNAL OF CELL SCIENCE
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Serelaxin-mediated signal transduction in human vascular cells: bell-shaped concentration-response curves reflect differential coupling to G proteins
- (2014) M Sarwar et al. BRITISH JOURNAL OF PHARMACOLOGY
- Serelaxin Is a More Efficacious Antifibrotic Than Enalapril in an Experimental Model of Heart Disease
- (2014) Chrishan S. Samuel et al. HYPERTENSION
- Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis
- (2014) Bryna S. Man Chow et al. KIDNEY INTERNATIONAL
- Pirfenidone Attenuates Cardiac Fibrosis in a Mouse Model of TAC-Induced Left Ventricular Remodeling by Suppressing NLRP3 Inflammasome Formation
- (2013) Yongliang Wang et al. CARDIOLOGY
- Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury
- (2013) Massimo Collino et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- IL-1 Induces Proinflammatory Leukocyte Infiltration and Regulates Fibroblast Phenotype in the Infarcted Myocardium
- (2013) A. Saxena et al. JOURNAL OF IMMUNOLOGY
- Relaxin Family Peptides and Their Receptors
- (2013) R. A. D. Bathgate et al. PHYSIOLOGICAL REVIEWS
- Relaxin Prevents Cardiac Fibroblast-Myofibroblast Transition via Notch-1-Mediated Inhibition of TGF-β/Smad3 Signaling
- (2013) Chiara Sassoli et al. PLoS One
- Toll-Like Receptor 4 Signaling Augments Transforming Growth Factor-β Responses
- (2012) Swati Bhattacharyya et al. AMERICAN JOURNAL OF PATHOLOGY
- Combination therapy with relaxin and methylprednisolone augments the effects of either treatment alone in inhibiting subepithelial fibrosis in an experimental model of allergic airways disease
- (2012) Simon G. Royce et al. CLINICAL SCIENCE
- Mechanisms of fibrosis: therapeutic translation for fibrotic disease
- (2012) Thomas A Wynn et al. NATURE MEDICINE
- Relaxin Signals through a RXFP1-pERK-nNOS-NO-cGMP-Dependent Pathway to Up-Regulate Matrix Metalloproteinases: The Additional Involvement of iNOS
- (2012) Bryna Suet Man Chow et al. PLoS One
- Relaxin Ameliorates Hypertension and Increases Nitric Oxide Metabolite Excretion in Angiotensin II But Not N ω -Nitro- l -Arginine Methyl Ester Hypertensive Rats
- (2011) Jennifer M. Sasser et al. HYPERTENSION
- Relaxin remodels fibrotic healing following myocardial infarction
- (2011) Chrishan S Samuel et al. LABORATORY INVESTIGATION
- Molecular physiology of cardiac regeneration
- (2010) Paola Bolli et al. Annals of the New York Academy of Sciences
- Relaxin inhibits early steps in vascular inflammation
- (2010) Anna Brecht et al. REGULATORY PEPTIDES
- Cardiovascular effects of relaxin: from basic science to clinical therapy
- (2009) Xiao-Jun Du et al. Nature Reviews Cardiology
- Higher levels of collagen and facilitated healing protect against ventricular rupture following myocardial infarction
- (2008) Lu Fang et al. CLINICAL SCIENCE
- Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2
- (2008) Ishanee Mookerjee et al. FASEB JOURNAL
- Mast cell inhibition and reduced ventricular arrhythmias in a swine model of acute myocardial infarction upon therapeutic administration of relaxin
- (2008) S. Nistri et al. INFLAMMATION RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started